Transfusion & Transplantation Technologies (3Ti) is a pre-revenue stage in-vitro diagnostics company developing novel automated blood testing instrumentation and associated consumables and services for the pre-transfusion (immunohematology) market. The firm's initial product, the Aegis Blood Analyzer and System, is being designed to perform highly accurate, rapid and cost-effective blood grouping (ABO and Rh), red cell antibody screening/identification and certain donor/recipient cross-matching tests, all with walk-away automation
